Integra LifeSciences Expands Uni-CP Compression System Product Range for Mid and Hindfoot Reconstruction
PLAINSBORO, N.J., July 16, 2009 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART – News) announced today that it will release multiple product line extensions to the Uni-CP(TM) Compression System. The Uni-CP(TM) Compression System has U.S. Food and Drug Administration (FDA) clearance in the United States and a CE Mark Certification in the European Union. Integra will feature the product line extensions at the 25th Annual Summer Meeting of the American Orthopaedic Foot and Ankle Society, July 15-18, 2009, Vancouver, British Columbia, Canada.
“The multiple line extensions for the Uni-CP(TM) Compression System will provide our customers with even greater clinical flexibility when using our highly successful product line,” said Pete Ligotti, Vice President, Sales and Marketing, Integra Extremity Reconstruction. “The T-plate offers anatomic metatarsal fixation for demanding procedures such as Lapidus and first metatarsal-cuneiform fusions. The surgeon is also able to choose between staple and plate fixation for Lisfranc procedures.”
The Uni-CP(TM) Compression System currently includes a line of compression plates and staples designed for the correction and stabilization of osteotomies and fusions in the foot. Each product employs a diamond shaped bridge design to provide compression through controlled deformation of the implant by the surgeon. The Uni-CP(TM) Compression plates use Surfix® locking technology that enables the surgeon to place the plate at the optimal distance from the bone and then lock the screws.
